|
|
Administration Core |
| 1P01AG073090-01A1 |
|
NIA |
2022 |
|
|
Parenchymal border macrophages in AD and CAA |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Project 2 - Astrocytic insulin signaling and AD |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Molecular Mechanism of the Parkinsons Disease-associated protein LRRK2 |
| 1R01AG075132-01A1 |
|
NIA |
2022 |
|
|
Developing a Prediction Model to Improve End‐of‐Life Prognostication and Hospice Referral in Parkinsons Disease |
| 1R21AG075524-01A1 |
|
NIA |
2022 |
|
|
NIA/AA for Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (NIA/AA IMPACT-AD Course) |
| 1R25AG076392-01 |
|
NIA |
2022 |
|
|
The Hopkins Undergraduate Summer Training and Research (USTAR) Program |
| 1R25AG076635-01 |
|
NIA |
2022 |